Get the Stockscreener App
75.61
3.29%
-2.785
Corcept Therapeutics Inc stock is traded at $75.61, with a volume of 209.35K.
It is down -3.29% in the last 24 hours and up +5.99% over the past month.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
See More
Previous Close:
$78.39
Open:
$77.54
24h Volume:
209.35K
Relative Volume:
0.26
Market Cap:
$7.98B
Revenue:
$628.56M
Net Income/Loss:
$141.82M
P/E Ratio:
60.00
EPS:
1.26
Net Cash Flow:
$142.60M
1W Performance:
+3.77%
1M Performance:
+5.99%
6M Performance:
+7.40%
1Y Performance:
+34.30%
1-Day Range:
$75.70
$77.98
1-Week Range:
$70.74
$79.89
52-Week Range:
$49.00
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
Name
Corcept Therapeutics Inc
Sector
Industry
Phone
650.688.8803
Address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
75.70 | 8.25B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.92 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.88 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.62 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
892.18 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
367.12 | 41.77B | 4.56B | -176.77M | 225.30M | -1.7177 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-23 | Upgrade | Truist | Hold → Buy |
| Apr-11-23 | Initiated | SVB Securities | Market Perform |
| Apr-04-23 | Initiated | Piper Sandler | Overweight |
| Feb-15-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-22 | Downgrade | Truist | Buy → Hold |
| Jul-27-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-27-22 | Resumed | Canaccord Genuity | Buy |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Jan-28-22 | Initiated | Truist | Buy |
| Aug-05-20 | Downgrade | Jefferies | Buy → Hold |
| Sep-24-19 | Initiated | Jefferies | Buy |
| Sep-06-19 | Initiated | H.C. Wainwright | Buy |
| Feb-04-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Aug-10-18 | Reiterated | Stifel | Hold |
| May-31-18 | Downgrade | Stifel | Buy → Hold |
| Mar-09-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Aug-31-17 | Initiated | Stifel | Buy |
| Feb-02-17 | Initiated | Ladenburg Thalmann | Buy |
| Apr-21-15 | Initiated | FBR Capital | Outperform |
| Jan-13-14 | Downgrade | Stifel | Buy → Hold |
| Aug-09-13 | Downgrade | Janney | Buy → Neutral |
| Aug-09-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Feb-21-12 | Reiterated | JMP Securities | Mkt Outperform |
| Jan-06-10 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jul-17-08 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jun-21-07 | Upgrade | Punk, Ziegel & Co | Mkt Perform → Accumulate |
View All
Corcept Therapeutics Inc Stock (CORT) Latest News
Why Corcept Therapeutics Incorporated (HTD) stock is a must watch ticker2025 Buyback Activity & Free Safe Capital Growth Stock Tips - newser.com
Will Corcept Therapeutics Incorporated (HTD) stock return to pre crash levels2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock inflation resilientChart Signals & Consistent Profit Alerts - newser.com
Will a bounce in Corcept Therapeutics Incorporated offer an exitRate Cut & High Return Trade Opportunity Guides - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock undervalued at current priceJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com
Will Corcept Therapeutics Incorporated stock recover after recent drop2025 Sector Review & Safe Entry Point Alerts - newser.com
Using data models to predict Corcept Therapeutics Incorporated stock movement2025 Major Catalysts & Pattern Based Trade Signal System - newser.com
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know - Yahoo Finance
We Think You Can Look Beyond Corcept Therapeutics' (NASDAQ:CORT) Lackluster Earnings - Yahoo! Finance Canada
How high can Corcept Therapeutics Incorporated stock goJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
The 5 Most Interesting Analyst Questions From Corcept’s Q3 Earnings Call - TradingView
Risk vs reward if holding onto Corcept Therapeutics IncorporatedJuly 2025 Outlook & Stepwise Trade Signal Implementation - newser.com
How hedge fund analytics apply to Corcept Therapeutics Incorporated stockEarnings Summary Report & Detailed Earnings Play Alerts - newser.com
Insider Sell: William Guyer Sells 20,000 Shares of Corcept Thera - GuruFocus
Corcept therapeutics exec Guyer sells $1.5m in stock By Investing.com - Investing.com Canada
Corcept therapeutics exec Guyer sells $1.5m in stock - Investing.com India
Does Corcept Therapeutics Incorporated qualify in momentum factor screening2025 Investor Takeaways & Consistent Growth Stock Picks - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock a top pick for value investorsVolume Spike & Expert Curated Trade Setups - newser.com
Corcept Therapeutics president sells $1.48 million in shares By Investing.com - Investing.com South Africa
H.C. Wainwright Reaffirms Their Buy Rating on Corcept Therapeutics (CORT) - The Globe and Mail
Is Corcept Therapeutics Incorporated stock positioned well for digital economyQuarterly Market Review & Verified Technical Trade Signals - newser.com
Corcept therapeutics officer Lyon sells $368k in shares By Investing.com - Investing.com Philippines
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2025 Earnings Call Transcript - Insider Monkey
Will Corcept Therapeutics Incorporated (HTD) stock enhance shareholder valuePortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
Is Corcept Therapeutics Incorporated stock affected by interest rate hikesEarnings Beat & Low Drawdown Investment Strategies - newser.com
Does Recent Pipeline Progress Justify Corcept’s 53% Rally in 2025? - Yahoo Finance
Is Corcept Therapeutics Incorporated stock attractive for income investors2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
Peering Into Corcept Therapeutics Inc's Recent Short Interest - Sahm
How Corcept Therapeutics Incorporated stock compares to growth peersJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com
Corcept Therapeutics Inc Stock (CORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Corcept Therapeutics Inc Stock (CORT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Guyer William | Chief Development Officer |
Nov 05 '25 |
Sale |
75.36 |
20,000 |
1,507,122 |
5,287 |
| Lyon Joseph Douglas | See Remarks |
Nov 03 '25 |
Option Exercise |
13.56 |
5,000 |
67,800 |
15,277 |
| Lyon Joseph Douglas | See Remarks |
Nov 03 '25 |
Sale |
73.65 |
5,000 |
368,244 |
10,277 |
| BELANOFF JOSEPH K | Chief Executive Officer |
Nov 05 '25 |
Sale |
74.77 |
28,782 |
2,152,105 |
2,741,370 |
| BELANOFF JOSEPH K | Chief Executive Officer |
Nov 03 '25 |
Sale |
74.08 |
11,218 |
831,014 |
2,770,152 |
| Maduck Sean | See Remarks |
Nov 03 '25 |
Option Exercise |
8.27 |
20,000 |
165,400 |
27,904 |
| Maduck Sean | See Remarks |
Nov 03 '25 |
Sale |
73.99 |
20,000 |
1,479,816 |
7,904 |
0.16%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):